Cambridge Investment Research Advisors’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
PCM
Cambridge Investment Research Advisors's BCAT Position: Q1 2026 in Review
Cambridge Investment Research Advisors increased its BlackRock Capital Allocation Term Trust (BCAT) stake by 7.1% in Q1 2026, buying an estimated $225K and bringing the position to 229,609 shares worth $3.24M. The position accounts for 0.01% of the portfolio, ranked #1232.
Cambridge Investment Research Advisors first reported a position in BCAT in Q4 2020 and has held it in 19 quarters since. 100 funds tracked by Wall St. Rank hold BCAT as of Q1 2026.
- Cambridge Investment Research Advisors held 229,609 shares of BlackRock Capital Allocation Term Trust worth $3.24M as of Q1 2026.
- Cambridge Investment Research Advisors bought 15,260 BlackRock Capital Allocation Term Trust shares in Q1 2026, an estimated $225K.
- BlackRock Capital Allocation Term Trust made up 0.01% of Cambridge Investment Research Advisors's portfolio in Q1 2026, its #1232 holding.
- Cambridge Investment Research Advisors first reported a position in BlackRock Capital Allocation Term Trust in Q4 2020 and has held it in 19 quarters since.
- 100 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q1 2026.
Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.